Skip to main content
Premium Trial:

Request an Annual Quote

Ophiomics Liver Cancer Assay Gets CE-IVD Mark

NEW YORK —Biocartis announced on Monday Ophiomics has received CE-IVD marking for the HepatoPredict prognostic liver cancer assay to identify which patients would benefit most from a liver transplant.

Biocartis has started commercialization of the assay as a result.

Mechelen, Belgium-based Biocartis said the CE-IVD-marked gene expression signature test will help guide treatment of liver cancer patients who have hepatocellular carcinoma. Lisbon, Portugal-based biotech Ophiomics developed the test, and Biocartis will lead the product's commercialization in Europe through Biocartis' network of customers.

The firms announced the partnership in February along with plans to gauge commercial interest as Biocartis distributes the manual HepatoPredict kit. Depending on sales, the firms are considering development of a version for the Biocartis' fully automated real-time PCR-based Idylla instrument.

Ophiomics officials previously said an automated version of the assay would eliminate operator-induced variability and offer the potential to provide results the same day as a needle biopsy.

Biocartis said liver transplantation is the best treatment for hepatocellular carcinoma patients, but the current criteria often exclude patients who would benefit while overestimating the benefits to others. HepatoPredict aids tumor assessments through a combination of clinical parameters and molecular markers, it said.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.